A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease
Completed
- Conditions
- Saphenous Vein Graft Disease
- Registration Number
- NCT01036048
- Lead Sponsor
- Catholic University of the Sacred Heart
- Brief Summary
A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.
- Detailed Description
To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5806
Inclusion Criteria
- CABG disease
- randomized studies
- not randomized studies
Exclusion Criteria
- studies reporting composite and not single endpoints, duplicate reporting
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method death years depending from studies retrieved
- Secondary Outcome Measures
Name Time Method myocardial infarction years depending from study retrieved target vessel revascularization years depending from study retrieved
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie drug eluting stents' efficacy in saphenous vein graft disease compared to bare metal stents?
How does the use of drug eluting stents compare to bare metal stents in reducing target vessel revascularization rates for saphenous vein graft disease?
What biomarkers are associated with improved outcomes following drug eluting stent placement in saphenous vein graft disease?
What are the long-term safety profiles of drug eluting stents versus bare metal stents in saphenous vein graft disease patients?
Are there specific subtypes of saphenous vein graft disease where drug eluting stents demonstrate superior efficacy compared to bare metal stents?